Cargando…

Integrated bioinformatics analysis for the identification of idiopathic pulmonary fibrosis–related genes and potential therapeutic drugs

OBJECTIVE: The pathogenesis of idiopathic pulmonary fibrosis (IPF) remains unclear. We sought to identify IPF-related genes that may participate in the pathogenesis and predict potential targeted traditional Chinese medicines (TCMs). METHODS: Using IPF gene-expression data, Wilcoxon rank-sum tests w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhenzhen, Guan, Qingzhou, Tian, Yange, Shao, Xuejie, Zhao, Peng, Huang, Lidong, Li, Jiansheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552267/ https://www.ncbi.nlm.nih.gov/pubmed/37794454 http://dx.doi.org/10.1186/s12890-023-02678-z

Ejemplares similares

Identification of Potential Key Genes in the Pathogenesis of Chronic Obstructive Pulmonary Disease Through Bioinformatics Analysis
por: Guan, Qingzhou, et al.
Publicado: (2021)

Identification of cancer risk assessment signature in patients with chronic obstructive pulmonary disease and exploration of the potential key genes
por: Guan, Qingzhou, et al.
Publicado: (2022)

Identification of hub genes associated with COVID-19 and idiopathic pulmonary fibrosis by integrated bioinformatics analysis
por: Chen, Qianyi, et al.
Publicado: (2022)

Identification of Hub Genes and Pathways Associated With Idiopathic Pulmonary Fibrosis via Bioinformatics Analysis
por: Wan, Hanxi, et al.
Publicado: (2021)

Identification of autophagy-related genes in idiopathic pulmonary fibrosis using bioinformatics methods
por: Sun, Shulei, et al.
Publicado: (2022)

Critical appraisal of the quality of clinical practice guidelines for idiopathic pulmonary fibrosis
por: Li, Xuanlin, et al.
Publicado: (2020)

Identification and Validation of Potential Biomarkers and Pathways for Idiopathic Pulmonary Fibrosis by Comprehensive Bioinformatics Analysis
por: Qian, Weibin, et al.
Publicado: (2021)

Identification of Hub Genes in Idiopathic Pulmonary Fibrosis and Their Association with Lung Cancer by Bioinformatics Analysis
por: Velázquez-Enríquez, Juan Manuel, et al.
Publicado: (2023)

Drug repurposing in idiopathic pulmonary fibrosis filtered by a bioinformatics-derived composite score
por: Karatzas, E., et al.
Publicado: (2017)

Identification of diagnostic gene biomarkers related to immune infiltration in patients with idiopathic pulmonary fibrosis based on bioinformatics strategies
por: Dai, Xiangdong, et al.
Publicado: (2022)

Identification of Hub Genes in Idiopathic Pulmonary Fibrosis and NSCLC Progression:Evidence From Bioinformatics Analysis
por: Yao, Yuanshan, et al.
Publicado: (2022)

Identification of three hub genes related to the prognosis of idiopathic pulmonary fibrosis using bioinformatics analysis
por: Wang, Enze, et al.
Publicado: (2022)

Bioinformatic identification and analysis of immune-related chromatin regulatory genes as potential biomarkers in idiopathic pulmonary fibrosis
por: Li, Kaixin, et al.
Publicado: (2022)

Identification and validation of targets of swertiamarin on idiopathic pulmonary fibrosis through bioinformatics and molecular docking-based approach
por: Chang, Jun, et al.
Publicado: (2023)

Bioinformatic analysis of differentially expressed genes and pathways in idiopathic pulmonary fibrosis
por: Li, Nana, et al.
Publicado: (2021)

Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease
por: Zhao, Peng, et al.
Publicado: (2018)

The Anti-Inflammatory Effect of a Combination of Five Compounds From Five Chinese Herbal Medicines Used in the Treatment of COPD
por: Li, Jiansheng, et al.
Publicado: (2021)

Update on therapeutic management of idiopathic pulmonary fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2015)

Reconstruction of the miR-506-Quaking axis in Idiopathic Pulmonary Fibrosis using integrative multi-source bioinformatics
por: Stojanović, Stevan D., et al.
Publicado: (2021)

Network Pharmacology and Experimental Validation to Reveal Effects and Mechanisms of Icariin Combined with Nobiletin against Chronic Obstructive Pulmonary Diseases
por: Lu, Ruilong, et al.
Publicado: (2022)

Using bioinformatics approach identifies key genes and pathways in idiopathic pulmonary fibrosis
por: Xu, Zhongbo, et al.
Publicado: (2020)

Identification of targetable kinases in idiopathic pulmonary fibrosis
por: Higo, Hisao, et al.
Publicado: (2022)

An Integrative Multiomics Framework for Identification of Therapeutic Targets in Pulmonary Fibrosis
por: Arif, Muhammad, et al.
Publicado: (2023)

Identification of Hub Genes and MicroRNAs Associated With Idiopathic Pulmonary Arterial Hypertension by Integrated Bioinformatics Analyses
por: Qiu, Xue, et al.
Publicado: (2021)

Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges
por: Spagnolo, Paolo, et al.
Publicado: (2012)

Extracellular vesicles in idiopathic pulmonary fibrosis: pathogenesis and therapeutics
por: Fujita, Yu
Publicado: (2022)

Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis
por: Ma, Hongbo, et al.
Publicado: (2022)

Identification of Tamoxifen-Resistant Breast Cancer Cell Lines and Drug Response Signature
por: Guan, Qingzhou, et al.
Publicado: (2020)

Integrated analysis of the molecular mechanisms in idiopathic pulmonary fibrosis
por: Zhu, Ke, et al.
Publicado: (2021)

Incorporating genetics into the identification and treatment of Idiopathic Pulmonary Fibrosis
por: Mathai, Susan K., et al.
Publicado: (2015)

Integrative bioinformatics and validation studies reveal KDM6B and its associated molecules as crucial modulators in Idiopathic Pulmonary Fibrosis
por: Chen, Anning, et al.
Publicado: (2023)

Current and novel drug therapies for idiopathic pulmonary fibrosis
por: Adamali, Huzaifa I, et al.
Publicado: (2012)

Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: Rationale and therapeutic potential
por: Zhang, Yukun, et al.
Publicado: (2021)

Identification of key genes, pathways and potential therapeutic agents for liver fibrosis using an integrated bioinformatics analysis
por: Zhan, Zhu, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

The Potential Effects of Curcumin on Pulmonary Fibroblasts of Idiopathic Pulmonary Fibrosis (IPF)—Approaching with Next-Generation Sequencing and Bioinformatics
por: Chang, Wei-An, et al.
Publicado: (2020)

Idiopathic pulmonary fibrosis in 2011: key updates on guidelines and therapeutics
por: Costabel, U, et al.
Publicado: (2013)

Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis
por: Inomata, Minoru, et al.
Publicado: (2015)

Idiopathic and immune‐related pulmonary fibrosis: diagnostic and therapeutic challenges
por: McLean‐Tooke, Andrew, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6rfho55fgt9qq36b6gbv4r1irp